These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 33060800)

  • 1. Henceforth CRISPR.
    Nat Biomed Eng; 2020 Nov; 4(11):1023. PubMed ID: 33060800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. And Then There Were Three: Discovering the Role of CRISPRs.
    Vergnaud G
    CRISPR J; 2019 Dec; 2(6):359-361. PubMed ID: 31860354
    [No Abstract]   [Full Text] [Related]  

  • 3. A Decade of CRISPR Gene Editing in China and Beyond: A Scientometric Landscape.
    Zhou W; Yuan Y; Zhang Y; Chen D
    CRISPR J; 2021 Jun; 4(3):313-320. PubMed ID: 34152220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Director's Cut: An Interview with Adam Bolt.
    Davies K; Bolt A
    CRISPR J; 2019 Aug; 2():188-192. PubMed ID: 31436509
    [No Abstract]   [Full Text] [Related]  

  • 5. CRISPR to the Core.
    Lambert LJ
    CRISPR J; 2020 Dec; 3(6):433. PubMed ID: 33346714
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeted Base Editing Systems Are Available for Plants.
    Marzec M; Hensel G
    Trends Plant Sci; 2018 Nov; 23(11):955-957. PubMed ID: 30224156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Biology and Application Areas of CRISPR Technologies.
    Adli M
    J Mol Biol; 2019 Jan; 431(1):1-2. PubMed ID: 30447221
    [No Abstract]   [Full Text] [Related]  

  • 8. Meeting Report: German Genetics Society-Genome Editing with CRISPR.
    Maier LK; Marchfelder A; Randau L
    Bioessays; 2020 Feb; 42(2):e1900223. PubMed ID: 31853989
    [No Abstract]   [Full Text] [Related]  

  • 9. History of CRISPR-Cas from Encounter with a Mysterious Repeated Sequence to Genome Editing Technology.
    Ishino Y; Krupovic M; Forterre P
    J Bacteriol; 2018 Apr; 200(7):. PubMed ID: 29358495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CRISPR-Cas9 System: Opportunities and Concerns.
    Vasiliou SK; Diamandis EP; Church GM; Greely HT; Baylis F; Thompson C; Schmitt-Ulms G
    Clin Chem; 2016 Oct; 62(10):1304-11. PubMed ID: 27551006
    [No Abstract]   [Full Text] [Related]  

  • 11. Foresight is 2020: Ten Bold Predictions for the New CRISPR Year.
    Barrangou R
    CRISPR J; 2019 Dec; 2(6):341-342. PubMed ID: 31860348
    [No Abstract]   [Full Text] [Related]  

  • 12. The CRISPR-Antibiotic Resistance Connection.
    Gilmore MS
    CRISPR J; 2019 Aug; 2():199-200. PubMed ID: 31436505
    [No Abstract]   [Full Text] [Related]  

  • 13. Gene editing and gene regulation with CRISPR.
    Harrison P; Hart S
    Exp Physiol; 2018 Apr; 103(4):437-438. PubMed ID: 29603460
    [No Abstract]   [Full Text] [Related]  

  • 14. Cas9 immunity creates challenges for CRISPR gene editing therapies.
    Crudele JM; Chamberlain JS
    Nat Commun; 2018 Aug; 9(1):3497. PubMed ID: 30158648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refining CRISPR-based genome and epigenome editing off-targets.
    Luo Y
    Cell Biol Toxicol; 2019 Aug; 35(4):281-283. PubMed ID: 31227932
    [No Abstract]   [Full Text] [Related]  

  • 16. [Nobel Prize in Chemistry 2020 for gene editing with CRISPR / Cas9 technology].
    Lüthy IA; Lamb CA
    Medicina (B Aires); 2020; 80(6):738-740. PubMed ID: 33254128
    [No Abstract]   [Full Text] [Related]  

  • 17. CRISPR/Cas: a Nobel Prize award-winning precise genome editing technology for gene therapy and crop improvement.
    Li C; Brant E; Budak H; Zhang B
    J Zhejiang Univ Sci B; 2021 Apr; 22(4):253-284. PubMed ID: 33835761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future of CRISPR technologies in agriculture.
    Gao C
    Nat Rev Mol Cell Biol; 2018 May; 19(5):275-276. PubMed ID: 29382940
    [No Abstract]   [Full Text] [Related]  

  • 20. CRISPR off-targets: a question of context.
    Haeussler M
    Cell Biol Toxicol; 2020 Feb; 36(1):5-9. PubMed ID: 31734746
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.